Boehringer’s buyout of Sanofi business wins EU approval
Boehringer Ingelheim today received EU approval to acquire Sanofi’s animal-health business after agreeing to sell off several animal vaccines and medications. The European Commission said in a statement that the “two...To view the full article, register now.
Already a subscriber? Click here to view full article